Volastra Therapeutics Announces Drug Discovery Collaboration with Bristol Myers Squibb

Ocean Road Advisors has been a long-time investor in Volastra Therapeutics, providing seed financing to the company in 2017 during…

PierianDx and Biodesix Partner to Advance Lung Cancer Diagnostics

Meyer Ventures was a Lead Investor in PierianDx in 2015 alongside Healthcare Capital Catalyst Management and Anthony E. Meyer serves…

WSJ: Investors Bankroll Virtual-Care Startup 98point6 With $118 Million

Meyer Ventures participating in the Series E financing in 98point6.

PierianDX Reports that CMS Expands Coverage of Next Generation Sequencing as a Diagnostic Tool for Patients with Breast and Ovarian Cancer

Meyer Ventures was a Lead Investor in PierianDx in 2015 alongside Healthcare Capital Catalyst Management.

Intermountain Healthcare Selects PierianDx Clinical Genomics Solution and joins PierianDx’s partner network to accelerate precision medicine.

Meyer Ventures was a Lead Investor in the Series A financing for PierianDx in 2015 alongside Healthcare Capital Catalyst Management.

Horwitz Prize Awarded For Work on Critical Cancer Pathway

Lewis C. Cantley is the Director of the Meyer Cancer Center at Weill Cornell Medicine.

PierianDx Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics

Ocean Road Advisors is a co-lead Investor in PierianDx’s recent Series A financing alongside Health Catalyst Capital Management.

HealthMine CEO, Bryce Williams, presenting at the RISE Star Ratings Master Class: “Improving star quality ratings: how to think like a start-up to drive clinical health action”

Meyer Ventures is an investor in HealthMine, and Anthony Meyer serves on its Board of Directors.

PierianDx Announces Newest Customer Cleveland Clinic

Ocean Road Advisors is a co-lead Investor in PierianDx's recent Series A financing alongside Health Catalyst Capital Management.

HealthCorps In America

https://www.youtube.com/watch?v=nXmH8wlTUCw